*Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada
†Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada
‡Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario Canada
§Program in Population Genomics, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
¶Department of Pharmacy, The Hospital for Sick Children, Toronto, Ontario, Canada
â•‘Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
**Leeds Teaching Hospitals, NHS Trust, Leeds General Infirmary, Leeds, United Kingdom
††Department of Pediatric Hematology and Oncology, Johann Wolfgang Goethe-University Hospital, Frankfurt, Germany
Accepted for publication December 7, 2011.
Supported by a New Investigator Award with the Canadian Institutes of Health Research (grant 87719) (to L.S.); and from the Canadian Institute of Health Research, CIHR (grant 84392) (to J.B.). The authors have no other funding or conflicts of interest to disclose.
Address for correspondence: Lillian Sung, MD, PhD, Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Ave, Toronto, Ontario M5G 1X8, Canada. E-mail: [email protected].
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.pidj.com).
